Cargando…

Sample size estimation for randomised controlled trials with repeated assessment of patient-reported outcomes: what correlation between baseline and follow-up outcomes should we assume?

BACKGROUND: Patient-reported outcome measures (PROMs) are now frequently used in randomised controlled trials (RCTs) as primary endpoints. RCTs are longitudinal, and many have a baseline (PRE) assessment of the outcome and one or more post-randomisation assessments of outcome (POST). With such pre-t...

Descripción completa

Detalles Bibliográficos
Autores principales: Walters, Stephen J., Jacques, Richard M., dos Anjos Henriques-Cadby, Inês Bonacho, Candlish, Jane, Totton, Nikki, Xian, Mica Teo Shu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6743178/
https://www.ncbi.nlm.nih.gov/pubmed/31519202
http://dx.doi.org/10.1186/s13063-019-3671-2
_version_ 1783451234289582080
author Walters, Stephen J.
Jacques, Richard M.
dos Anjos Henriques-Cadby, Inês Bonacho
Candlish, Jane
Totton, Nikki
Xian, Mica Teo Shu
author_facet Walters, Stephen J.
Jacques, Richard M.
dos Anjos Henriques-Cadby, Inês Bonacho
Candlish, Jane
Totton, Nikki
Xian, Mica Teo Shu
author_sort Walters, Stephen J.
collection PubMed
description BACKGROUND: Patient-reported outcome measures (PROMs) are now frequently used in randomised controlled trials (RCTs) as primary endpoints. RCTs are longitudinal, and many have a baseline (PRE) assessment of the outcome and one or more post-randomisation assessments of outcome (POST). With such pre-test post-test RCT designs there are several ways of estimating the sample size and analysing the outcome data: analysis of post-randomisation treatment means (POST); analysis of mean changes from pre- to post-randomisation (CHANGE); analysis of covariance (ANCOVA). Sample size estimation using the CHANGE and ANCOVA methods requires specification of the correlation between the baseline and follow-up measurements. Other parameters in the sample size estimation method being unchanged, an assumed correlation of 0.70 (between baseline and follow-up outcomes) means that we can halve the required sample size at the study design stage if we used an ANCOVA method compared to a comparison of POST treatment means method. So what correlation (between baseline and follow-up outcomes) should be assumed and used in the sample size calculation? The aim of this paper is to estimate the correlations between baseline and follow-up PROMs in RCTs. METHODS: The Pearson correlation coefficients between the baseline and repeated PROM assessments from 20 RCTs (with 7173 participants at baseline) were calculated and summarised. RESULTS: The 20 reviewed RCTs had sample sizes, at baseline, ranging from 49 to 2659 participants. The time points for the post-randomisation follow-up assessments ranged from 7 days to 24 months; 464 correlations, between baseline and follow-up, were estimated; the mean correlation was 0.50 (median 0.51; standard deviation 0.15; range − 0.13 to 0.91). CONCLUSIONS: There is a general consistency in the correlations between the repeated PROMs, with the majority being in the range of 0.4 to –0.6. The implications are that we can reduce the sample size in an RCT by 25% if we use an ANCOVA model, with a correlation of 0.50, for the design and analysis. There is a decline in correlation amongst more distant pairs of time points.
format Online
Article
Text
id pubmed-6743178
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-67431782019-09-16 Sample size estimation for randomised controlled trials with repeated assessment of patient-reported outcomes: what correlation between baseline and follow-up outcomes should we assume? Walters, Stephen J. Jacques, Richard M. dos Anjos Henriques-Cadby, Inês Bonacho Candlish, Jane Totton, Nikki Xian, Mica Teo Shu Trials Methodology BACKGROUND: Patient-reported outcome measures (PROMs) are now frequently used in randomised controlled trials (RCTs) as primary endpoints. RCTs are longitudinal, and many have a baseline (PRE) assessment of the outcome and one or more post-randomisation assessments of outcome (POST). With such pre-test post-test RCT designs there are several ways of estimating the sample size and analysing the outcome data: analysis of post-randomisation treatment means (POST); analysis of mean changes from pre- to post-randomisation (CHANGE); analysis of covariance (ANCOVA). Sample size estimation using the CHANGE and ANCOVA methods requires specification of the correlation between the baseline and follow-up measurements. Other parameters in the sample size estimation method being unchanged, an assumed correlation of 0.70 (between baseline and follow-up outcomes) means that we can halve the required sample size at the study design stage if we used an ANCOVA method compared to a comparison of POST treatment means method. So what correlation (between baseline and follow-up outcomes) should be assumed and used in the sample size calculation? The aim of this paper is to estimate the correlations between baseline and follow-up PROMs in RCTs. METHODS: The Pearson correlation coefficients between the baseline and repeated PROM assessments from 20 RCTs (with 7173 participants at baseline) were calculated and summarised. RESULTS: The 20 reviewed RCTs had sample sizes, at baseline, ranging from 49 to 2659 participants. The time points for the post-randomisation follow-up assessments ranged from 7 days to 24 months; 464 correlations, between baseline and follow-up, were estimated; the mean correlation was 0.50 (median 0.51; standard deviation 0.15; range − 0.13 to 0.91). CONCLUSIONS: There is a general consistency in the correlations between the repeated PROMs, with the majority being in the range of 0.4 to –0.6. The implications are that we can reduce the sample size in an RCT by 25% if we use an ANCOVA model, with a correlation of 0.50, for the design and analysis. There is a decline in correlation amongst more distant pairs of time points. BioMed Central 2019-09-13 /pmc/articles/PMC6743178/ /pubmed/31519202 http://dx.doi.org/10.1186/s13063-019-3671-2 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Methodology
Walters, Stephen J.
Jacques, Richard M.
dos Anjos Henriques-Cadby, Inês Bonacho
Candlish, Jane
Totton, Nikki
Xian, Mica Teo Shu
Sample size estimation for randomised controlled trials with repeated assessment of patient-reported outcomes: what correlation between baseline and follow-up outcomes should we assume?
title Sample size estimation for randomised controlled trials with repeated assessment of patient-reported outcomes: what correlation between baseline and follow-up outcomes should we assume?
title_full Sample size estimation for randomised controlled trials with repeated assessment of patient-reported outcomes: what correlation between baseline and follow-up outcomes should we assume?
title_fullStr Sample size estimation for randomised controlled trials with repeated assessment of patient-reported outcomes: what correlation between baseline and follow-up outcomes should we assume?
title_full_unstemmed Sample size estimation for randomised controlled trials with repeated assessment of patient-reported outcomes: what correlation between baseline and follow-up outcomes should we assume?
title_short Sample size estimation for randomised controlled trials with repeated assessment of patient-reported outcomes: what correlation between baseline and follow-up outcomes should we assume?
title_sort sample size estimation for randomised controlled trials with repeated assessment of patient-reported outcomes: what correlation between baseline and follow-up outcomes should we assume?
topic Methodology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6743178/
https://www.ncbi.nlm.nih.gov/pubmed/31519202
http://dx.doi.org/10.1186/s13063-019-3671-2
work_keys_str_mv AT waltersstephenj samplesizeestimationforrandomisedcontrolledtrialswithrepeatedassessmentofpatientreportedoutcomeswhatcorrelationbetweenbaselineandfollowupoutcomesshouldweassume
AT jacquesrichardm samplesizeestimationforrandomisedcontrolledtrialswithrepeatedassessmentofpatientreportedoutcomeswhatcorrelationbetweenbaselineandfollowupoutcomesshouldweassume
AT dosanjoshenriquescadbyinesbonacho samplesizeestimationforrandomisedcontrolledtrialswithrepeatedassessmentofpatientreportedoutcomeswhatcorrelationbetweenbaselineandfollowupoutcomesshouldweassume
AT candlishjane samplesizeestimationforrandomisedcontrolledtrialswithrepeatedassessmentofpatientreportedoutcomeswhatcorrelationbetweenbaselineandfollowupoutcomesshouldweassume
AT tottonnikki samplesizeestimationforrandomisedcontrolledtrialswithrepeatedassessmentofpatientreportedoutcomeswhatcorrelationbetweenbaselineandfollowupoutcomesshouldweassume
AT xianmicateoshu samplesizeestimationforrandomisedcontrolledtrialswithrepeatedassessmentofpatientreportedoutcomeswhatcorrelationbetweenbaselineandfollowupoutcomesshouldweassume